PCR-based diagnostics Roche to Acquire TIB Molbiol to Expand Infectious Disease Test Portfolio TIB Molbiol already has more than 45 CE-marked tests available on Roche's LightCycle PCR instruments and its MagNA Pure sample prep systems. CRISPR-Based Wearable Diagnostics Enable SARS-CoV-2 Detection Through Mask Premium Synthetic biology and CRISPR have enabled researchers to develop wearable sensors that can detect a variety of viruses and bacteria, including SARS-CoV-2. Hologic Banking on MDx Acquisitions to Elevate Long-Term Revenue Growth Premium The company has invested revenues from its pandemic testing business to buy assets that are growing faster than its base business. ACMG Presentation Highlights Broad Institute's Massive Expansion of COVID-19 Testing Program The Broad's clinical research sequencing lab now runs 135,000 tests each day and routinely tests more than 100 higher education sites and 40 schools in the state. Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel The assay runs on the firm's rapid molecular diagnostics instrument, the PCR One, in approximately 15 minutes. Feb 25, 2021 German Nucleic Acid Sample Prep Startup Rides COVID-19 Testing, Automation Waves Premium Jan 5, 2021 Illumina, Helix Collaborate on CDC-Coordinated Coronavirus Surveillance Sep 15, 2020 Fulgent Genetics Wins Utah COVID-19 Testing Contract Sep 9, 2020 Fulgent Genetics Shares Rise on News of Miami-Dade County Coronavirus Testing Deal Aug 19, 2020 Oppenheimer Initiates Coverage of Fulgent Genetics With Outperform Rating Aug 17, 2020 Fulgent Genetics Opens CLIA-Certified Lab in Houston, Raises Revenue Guidance Aug 6, 2020 SARS-CoV-2 Study Documents Viral Dynamics in Young Adults With or Without Symptoms Aug 5, 2020 Fulgent Genetics Touts Returns on COVID-19 Testing Investment Premium Aug 4, 2020 Fulgent Genetics Revenues More Than Double in Q2, Driven by COVID-19 Testing Jul 31, 2020 NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics Jun 26, 2020 Iowa Startup FBB Biomed Pursues RNA Blood Test to Predict COVID-19 Disease Severity Premium May 20, 2020 Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing Premium May 15, 2020 Case Study Shows Power of SARS-CoV-2 Genome Testing to Track Viral Spread, ID Strains Premium May 4, 2020 Fulgent Genetics Q1 Revenues Jump 44 Percent Apr 29, 2020 UCSF, Stanford, CZ Biohub Receive $13.6M to Study Bay Area COVID-19 Spread Apr 16, 2020 UCSF, Mammoth Bio Develop Rapid Coronavirus Diagnostic Using CRISPR-Cas12 Method Mar 25, 2020 Sentinel Diagnostics Looks to Expand Global Influence With SARS-CoV-2 Test Mar 3, 2020 Ubiquitome Pushes Compact PCR System for Decentralized Coronavirus Testing Premium Feb 24, 2020 Luminex Submits Verigene II Respiratory Assay for FDA Clearance Feb 14, 2020 BGI Distributes More Than 230K Coronavirus Test Kits Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.